(Press-News.org) INDIANAPOLIS --More than 8 million people, ages 40 and older, living in the U.S. are affected by peripheral arterial disease, a lifelong medical condition and the most common cause of limb amputation in the country. A data scientist, health services researcher and vascular surgeon who studies health equity, Andrew A. Gonzalez, M.D., J.D., MPH, of the Regenstrief Institute and the Indiana University School of Medicine, has received a 2024 Ralph W. and Grace M. Showalter Research Trust award to conduct a new study, Exploring Causes of Racial Disparities in Amputation Rates in Indiana.
Dr. Gonzalez will analyze statewide clinical data from the Indiana Network for Patient Care (INPC) to explore racial disparities in vascular care leading to peripheral arterial disease associated amputation in Indiana, including whether minority patients have lower rates of adherence to best practices associated with better outcomes in both the pre-operative and post-operative phases of care for peripheral arterial disease.
He will also identify upstream drivers of racial disparities in peripheral arterial disease.
The INPC, created by the Regenstrief Institute and now managed by the Indiana Health Information Exchange, is the nation’s largest inter-organizational clinical and claims data repository, containing more than 16 billion clinical data items from throughout the state.
Black individuals have a significantly higher lifetime risk of peripheral arterial disease than Whites or Hispanics but are less likely to be diagnosed and treated. Treatment of peripheral arterial disease may reduce the risk of amputation, heart attack or stroke.
Dr. Gonzalez notes, “The Showalter award supports work that will enable our ability to conduct more sophisticated future studies that will involve injecting context such as geographic specificity. We will also develop empirical data to support interventional studies targeting particular upstream drivers of racial disparities in amputation rates that we identify.”
The Ralph W. and Grace M. Showalter Research Trust was established in 1975 to support medical and scientific research at Indiana University and Purdue University. Priority for support is given to projects that have a high potential to compete for or leverage federal funding and to create programs with a life span longer than the Showalter award.
Andrew Gonzalez, M.D., J.D., MPH
In addition to his role as a research scientist and associate director for data science with the William M. Tierney Center for Health Services Research at Regenstrief Institute, Andrew Gonzalez, M.D., J.D., MPH, is a practicing vascular surgeon and an assistant professor of surgery at the Indiana University School of Medicine. Dr. Gonzalez is also a faculty affiliate with the Regenstrief Center for Healthcare Engineering at Purdue University.
END
Gonzalez receives award to study causes of racial disparities in amputation rates in Indiana
2024-10-10
ELSE PRESS RELEASES FROM THIS DATE:
Mount Sinai opens state-of-the-art center for patients with complex conditions including Lyme disease and long COVID
2024-10-10
Mount Sinai’s Department of Rehabilitation and Human Performance has announced the grand opening of the Cohen Center for Recovery From Complex Chronic Illnesses (CoRE), providing clinical care for patients with conditions such as long Lyme disease/Lyme+, long COVID, and other infection-associated complex chronic illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Ehlers-Danlos syndrome (EDS).
Supported by philanthropy from various donors, including an inaugural gift from Beth and ...
$14M NIH grant funds gene-editing research for rare metabolic diseases at Penn and CHOP
2024-10-10
PHILADELPHIA— A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children’s Hospital of Philadelphia (CHOP). The research will focus specifically on developing therapies for urea cycle disorders, which impact roughly 1 in every 35,000 children. Using a form of CRISPR technology, the ultimate vision of the four-year grant is to create a platform for rapid development of personalized gene-editing therapies for ...
One experiment: The brain’s landscapers
2024-10-10
Imagine yourself sometime in the far future aboard a routine rocket to Mars. Someone just spilled their drink. Without gravity, it collects in floating blobs that ripple right before your eyes. Now freeze.
What you see might look something like the above image from Cold Spring Harbor Laboratory’s (CSHL’s) Cheadle lab. But those purple and green blobs aren’t the floating remains of somebody’s drink. They’re mysterious cells in the brain’s visual cortex called OPCs.
The visual cortex processes everything we see. Incoming visual information is ...
AI-supported dermatology: Now for darker skin tones too, thanks to a new data set
2024-10-10
In many countries in Africa, up to nine out of ten children suffer from a skin problem, and there are far too few local dermatologists. Artificial intelligence could help with diagnosis, but needs to be trained with the relevant images, so researchers have created a new data set for dark skin tones.
Demand is high, the lack of dermatologists acute: in many countries in Africa, there is less than one dermatology specialist per one million people – compared to the World Health Organization (WHO) recommendation of ...
Understanding how smiling influences relationship building during real-life conversations
2024-10-10
Smiling during conversations creates warmth, making people feel more comfortable and connected. For example, a friendly smile when meeting someone new can ease nervousness. A smile can soften tension in a debate, showing respect among the participants despite disagreement. In fact, extensive studies have been conducted in the past in an attempt to understand smiling interactions in a natural conversation. Despite these studies, however, little is known about the extent to which one’s smile influences or gets affected by the other person’s smile during a conversation.
A new study sought to investigate this by quantifying ...
British Heart Foundation Data Science Centre launches first open challenge to explore AI ECG potential
2024-10-10
The British Heart Foundation (BHF) Data Science Centre, led by Health Data Research UK, is hosting an open challenge which invites competitors to explore the potential of Artificial Intelligence to improve the use of electrocardiogram (ECG) for cardiovascular disease patient care. The challenge has been co-designed with members of public and patients affected by cardiovascular disease.
The BHF Data Science Centre is collaborating with experts from the University of Edinburgh to use a synthetic imaging dataset made up of approximately 20,000 simulated electrocardiogram (ECG) images. Competitors will be invited to develop algorithms which can make ...
Heart failure, atrial fibrillation & coronary heart disease linked to cognitive impairment
2024-10-10
Statement Highlights:
Previous studies have found that 14-81% of patients with heart failure experience some degree of cognitive impairment affecting language, memory or executive function.
Evidence also indicates that people with atrial fibrillation have a 39% increased risk of memory or thinking problems; adults with heart disease have a 27% higher risk of developing dementia; and up to 50% of individuals experience cognitive decline after a heart attack.
Managing heart health from an early age is important, not only for preventing heart disease but also for protecting brain health and reducing the risk of cognitive impairment in later life.
Embargoed until 4:00 a.m. CT/5:00 ...
To make children better fact-checkers, expose them to more misinformation — with oversight
2024-10-10
In an era when online misinformation is seemingly everywhere and objective facts are often in dispute, UC Berkeley psychologists in a new study have presented a somewhat paradoxical partial solution: Expose young children to more misinformation online — not less.
Doing so in limited circumstances, and with careful oversight and education, can help children gain the tools they'll need to sort fact from fiction online, said Evan Orticio, a Ph.D. student in UC Berkeley’s Department of Psychology and lead author of a paper published today ...
Renowned psychiatrist professor Celso Arango advocates for primary prevention in mental health
2024-10-10
In a revealing Genomic Press Interview published in Brain Medicine on October 10, 2024, Professor Celso Arango, a prominent psychiatrist and researcher, outlines his vision for the future of mental health care. Professor Arango, who serves as Director of the Institute of Psychiatry and Mental Health at Hospital General Universitario Gregorio Marañón and Professor of Psychiatry at the Universidad Complutense de Madrid, advocates for a paradigm shift towards primary prevention in psychiatry.
Professor Arango's career trajectory, from his early exposure to ...
Ketamine pioneer Dr. Carlos A. Zarate Jr. reshapes depression treatment landscape
2024-10-10
Bethesda, Maryland - 10 October 2024. In a revealing Genomic Press Interview published on 10 October 2024, Dr. Carlos A. Zarate Jr., NIH Distinguished Investigator and pioneer in rapid-acting antidepressant research, offers a glimpse into the personal motivations and scientific breakthroughs that have defined his career. The interview, part of the journal's Innovators and Ideas series, showcases Dr. Zarate's journey from a young tennis instructor in Argentina to a leading figure in psychiatric research at the National Institute ...